top of page

BioVenture VoiCes Episode 49: Sanofi Ventures' Jason Hafler

1 day ago
1 min read

Jason Hafler shares an overview of the corporate side of the venture world. He describes the unique value that he believes a corporate based VC can bring to the companies it invests in. Plus, his description of cases where investments might ultimately be a good fit for BD and/or M&A within the company, and why an investment might ultimately land at a different suitor.




Chapters

Intro and early life - 1:42

Cambridge - 9:18

Flagship - 12:48

Atlas - 18:57

RaNA Therapeutics - 20:48

Joining Sanofi - 26:01

Corporate venture - 38:15

Vega Therapeutics - 49:31

Sanofi's corporate focus - 51:13

Advice for founders - 56:21

Personal life - 1:02:40

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page